arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Lifeward Ltd.

LFWD
$7.59 ▲ +0.30 (+4.19%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
15 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Lifeward Ltd. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $8.8M
Dividend Yield
Revenue Growth -14.1%
Op. Margin -89.3%
ROIC -233.3%
FCF / Share $-14.51
Trailing P/E
Price / Book 1.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$22.03M
↓ -14.1%
Net Income Profit after all expenses
$-19.91M
↑ +31.2%
Operating Margin Operating profit as % of sales
-89.3%
↑ +21.9% 3th
FCF / Share Free cash flow per share
$-14.51
↓ -480.8%
Long-Term Debt Long-term obligations
$1.53M
↓ -78.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
1
Financial Health
16
Cash Quality
57

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 49 quarters